Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Kreienberg

Showing results (1-10 of 214) with videos related to

Pageof 22
Sort By:
Praxis|June 12, 1998
[Therapy of anthracycline-resistant metastatic breast carcinoma]R Kreienberg
Der Gynakologe|June 1, 1990
[Immunodiagnosis and its relevance in neoplastic disease, immunotherapy in neoplastic disease]R Kreienberg
Archives of Gynecology and Obstetrics|January 1, 1987
[New knowledge on immunology in gynecologic cancer]R Kreienberg
Der Gynakologe|September 1, 1986
[Possibilities and limits of the study of tumor markers in the after-care of patients with ovarian cancer]R Kreienberg
Der Gynakologe|February 1, 1989
[General and specific laboratory parameters within the scope of tumor after-care in gynecologic malignancies and breast cancer]R Kreienberg
Der Gynakologe|August 1, 1991
[Adjuvant chemotherapy in breast and ovarian carcinoma]R Kreienberg
American Journal of Clinical Oncology|January 1, 1991
Droloxifene-induced spikes of tumor markers predict benefit of therapyR Kreienberg
MMW Fortschritte Der Medizin|July 18, 2003
[From alcohol abstinence to total surgery. Preventive strategies in breast carcinoma]R Kreienberg, A Kafka
Deutsche Medizinische Wochenschrift (1946)|February 4, 1994
[Cervical carcinoma stage Ia/2]R Kreienberg, W Böhm
Archives of Gynecology and Obstetrics|December 29, 2000
Sentinel node mapping in gynecologic malignanciesT Kuehn, R Kreienberg
Pageof 22

Showing results (1-10 of 214) with videos related to

Sort By:
Pageof 22
Praxis|June 12, 1998
[Therapy of anthracycline-resistant metastatic breast carcinoma]R Kreienberg
Der Gynakologe|June 1, 1990
[Immunodiagnosis and its relevance in neoplastic disease, immunotherapy in neoplastic disease]R Kreienberg
Archives of Gynecology and Obstetrics|January 1, 1987
[New knowledge on immunology in gynecologic cancer]R Kreienberg
Der Gynakologe|September 1, 1986
[Possibilities and limits of the study of tumor markers in the after-care of patients with ovarian cancer]R Kreienberg
Der Gynakologe|February 1, 1989
[General and specific laboratory parameters within the scope of tumor after-care in gynecologic malignancies and breast cancer]R Kreienberg
Der Gynakologe|August 1, 1991
[Adjuvant chemotherapy in breast and ovarian carcinoma]R Kreienberg
American Journal of Clinical Oncology|January 1, 1991
Droloxifene-induced spikes of tumor markers predict benefit of therapyR Kreienberg
MMW Fortschritte Der Medizin|July 18, 2003
[From alcohol abstinence to total surgery. Preventive strategies in breast carcinoma]R Kreienberg, A Kafka
Deutsche Medizinische Wochenschrift (1946)|February 4, 1994
[Cervical carcinoma stage Ia/2]R Kreienberg, W Böhm
Archives of Gynecology and Obstetrics|December 29, 2000
Sentinel node mapping in gynecologic malignanciesT Kuehn, R Kreienberg
Pageof 22